Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

31.01 -0.39 (-1.26%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,354,295
Open 30.60
Bid (Size) 31.02 (100)
Ask (Size) 31.99 (200)
Prev. Close 31.41
Today's Range 30.60 - 31.73
52wk Range 25.16 - 36.45
Shares Outstanding 166,121,384
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Alkermes Eyes Global Phase 3 Trial After Encouraging Data From Sleep Disorder Study ↗
Alkermes' alixorexton met key goals in a phase 2 study for narcolepsy type 2, showing significant improvements in wakefulness and sleepiness scores. 
Via Benzinga

Performance

YTD
+7.9%
+7.9%
1 Month
-2.9%
-2.9%
3 Month
+9.7%
+9.7%
6 Month
-0.6%
-0.6%
1 Year
+6.1%
+6.1%

More News

Read More
News headline image
This Alkermes Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗
Via Benzinga
News headline image
ALKERMES PLC (NASDAQ:ALKS) Q3 2025 Earnings Beat Estimates and Drive Stock Surge ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For October 28, 2025 ↗
Via Benzinga
News headline image
Preview: Alkermes's Earnings ↗
Via Benzinga
News headline image
Earnings Scheduled For July 29, 2025 ↗
Via Benzinga
News headline image
Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups ↗
Via Benzinga
Topics Government
News headline image
Breaking Down Alkermes: 8 Analysts Share Their Views ↗
Via Benzinga
News headline image
Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz ↗
Via Benzinga
News headline image
Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition
Via MarketMinute
Topics Intellectual Property
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives. ↗
Via Investor's Business Daily
News headline image
Avadel Stock Rises After Acquisition Offer By Alkermes ↗
Via Stocktwits
News headline image
9 Analysts Assess Alkermes: What You Need To Know ↗
Via Benzinga
News headline image
This Ciena Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday ↗
Via Benzinga
News headline image
Deep Dive Into Alkermes Stock: Analyst Perspectives (7 Ratings) ↗
Via Benzinga
News headline image
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday ↗
Via Benzinga
News headline image
This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
Via Benzinga
News headline image
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
ALKERMES PLC (NASDAQ:ALKS) Emerges as a Top Value Pick with Strong Fundamentals and Undervalued Metrics ↗
Via Chartmill
News headline image
Alkermes PLC (NASDAQ:ALKS) Surges 7.8% Pre-Market After Q2 2025 Earnings Beat Revenue and EPS Estimates ↗
Via Chartmill
Topics Earnings
News headline image
Alkermes Q2 Sales Up 14 Percent ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives. ↗
Via Investor's Business Daily
News headline image
Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study ↗
Via Benzinga

Frequently Asked Questions

Is Alkermes plc - Ordinary Shares publicly traded?
Yes, Alkermes plc - Ordinary Shares is publicly traded.
What exchange does Alkermes plc - Ordinary Shares trade on?
Alkermes plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alkermes plc - Ordinary Shares?
The ticker symbol for Alkermes plc - Ordinary Shares is ALKS on the Nasdaq Stock Market
What is the current price of Alkermes plc - Ordinary Shares?
The current price of Alkermes plc - Ordinary Shares is 31.01
When was Alkermes plc - Ordinary Shares last traded?
The last trade of Alkermes plc - Ordinary Shares was at 11/13/25 04:00 PM ET
What is the market capitalization of Alkermes plc - Ordinary Shares?
The market capitalization of Alkermes plc - Ordinary Shares is 5.15B
How many shares of Alkermes plc - Ordinary Shares are outstanding?
Alkermes plc - Ordinary Shares has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.